Evidence map›Paper›PMID 42427653›Full record

ArticlebioRxiv : the preprint server for biology2026

Acute in vivo proximity labeling for membrane targeted proteomics in neuronal circuits.

Maribel Anguiano, Run Zhang, Melanie Robles, Kaden P Adams, Michelle R Salemi, Brett S Phinney, Christopher S Leung, Ethan M Fenton, Kuldeep Giri, Elinor Lewis and 4 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Maribel AnguianoPrinceton Neuroscience Institute, Princeton, NJ, USA.ORCID 0000-0002-4473-4124
Run ZhangBiomedical Engineering Graduate Group, University of California, Davis, Davis, CA, USA.
Melanie RoblesDepartment of Neurology, School of Medicine, University of California, Davis, Sacramento, CA, USA.
Kaden P AdamsPrinceton Neuroscience Institute, Princeton, NJ, USA.
Michelle R SalemiProteomics Core Facility, University of California, Davis, Davis, CA, USA.
Brett S PhinneyProteomics Core Facility, University of California, Davis, Davis, CA, USA.
Christopher S LeungPrinceton Neuroscience Institute, Princeton, NJ, USA.
Ethan M FentonCenter for Neuroscience, University of California, Davis, Davis, CA, USA.
Kuldeep GiriPrinceton Neuroscience Institute, Princeton, NJ, USA.
Elinor LewisPrinceton Neuroscience Institute, Princeton, NJ, USA.
Sophia LinDepartment of Neurology, School of Medicine, University of California, Davis, Sacramento, CA, USA.
Jennifer L WhistlerCenter for Neuroscience, University of California, Davis, Davis, CA, USA.
Alex S NordCenter for Neuroscience, University of California, Davis, Davis, CA, USA.ORCID 0000-0003-4259-7514
Christina K KimPrinceton Neuroscience Institute, Princeton, NJ, USA.ORCID 0000-0002-1466-7098

Funding

Functional Elucidation of the Sequence-Encoded Regulatory Activity of Enhancers in Vivo in the BrainR35GM119831 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Alexander Nord · 2016 to 2026
$3.9M
UC Davis Advancing Diversity in the Neuroscience Research (ADNR) ProgramR25NS112130 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI USREY, W MARTIN · 2019 to 2023
$1.2M
QE-HF-X Mass SpectrometerS10OD026918 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI PHINNEY, BRETT S · 2020 to 2020
$600k
Engineering chemoproteomic tools for identifying molecular mechanisms of substance use disordersR21DA059842 · NIDA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KIM, CHRISTINA · 2024 to 2025
$436k
Transcriptomic and Epigenomic Investigation of Antidepressant and Non-Hallucinogenic Serotonin Receptor AgonistsF31DA062491 · NIDA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Ethan Marsh Fenton · 2025 to 2026
$86k
Molecular and Cellular Determinants of Tolerance to Second Generation AntipsychoticsF31MH138072 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Elinor Lewis · 2024 to 2026
$77k
NIDA NIH HHS F31 DA062491NIDA NIH HHS R21 DA059842NIGMS NIH HHS R35 GM119831NIH HHS S10 OD026918NIMH NIH HHS F31 MH138072NINDS NIH HHS R25 NS112130
6 · The paper itself

Abstract

motivationDespite the growing use of proximity labeling tools, there are limited techniques available to identify subcellularly localized proteins within targeted neuronal circuits on acute timescales in vivo. We engineered membrane targeted versions of the proximity labeling enzyme TurboID and validated their use for proteomic discovery in the mouse brain. We optimized an in vivo protocol to identify proteins in cell bodies and long range neuronal projections, and proteins differentially detected during acute drug labeling windows. SUMMARY: A major goal within molecular systems neuroscience is to bridge the study of neuronal circuit function with changes in protein expression and localization in awake behaving animals. However, there are limited tools for capturing changes in subcellularly-defined proteomes within neuronal circuits during activity-gated timescales in vivo. Here, we engineered targeted versions of the proximity labeling enzyme TurboID, to tag proteins at the neuronal membrane during a user-delivered biotin injection. We optimized a labeling strategy that enables a one-to-two-hour labeling window and tagged proteins in medial prefrontal cortex (mPFC) cell bodies and corresponding axons in a downstream projection. We performed proteomics to identify proteins enriched in mPFC cell bodies and terminals, and upregulated in mPFC cell bodies following an acute cocaine injection. These advancements enable the detection of proteins at the subcellular level within short labeling windows, allowing identification of stimulus-specific proteomes in behaving mice.

Indexed as

axonal proteomicscocainemedial prefrontal cortexneuronal circuit projectionsproximity labelingsubcellular proteomicsTurboID

Identifiers

PMID42427653
PMCPMC13345169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.